thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVAXIN production to be demand-driven, says Bharat Biotech

COVID Vaccines

COVAXIN production to be demand-driven, says Bharat Biotech

TheNewsFacts
Last updated: April 13, 2023 8:05 pm
TheNewsFacts
Share
COVAXIN
Covaxin: Facts vs. Fiction - Separating Truth from Misinformation
SHARE

Bharat Biotech, the Hyderabad-based vaccine maker of COVAXIN, announced that it will wait and assess the demand before resuming the production of the indigenously developed COVID-19 vaccine. The move comes as India sees a resurgence of COVID-19 cases in various parts of the country.

Contents
Bharat Biotech to develop antigen bank of 10 Million iNCOVACCCOVAXIN

“Covaxin is available for supplies based on demand,” Bharat Biotech stated. The company had earlier stopped the production of Covaxin in early 2022, citing declining offtake for the product, and the number of viral infection cases.

Moreover, the company revealed that around 50 million doses of Covaxin had to be destroyed over the past few months “due to non-procurement, at a great loss for the company”. Meanwhile, Bharat Biotech’s competitor, Serum Institute of India, has already resumed the production of its COVID-19 vaccine, Covishield.

Bharat Biotech clarified that it is waiting for the demand to surge before resuming COVAXIN’S production. “We have more than 200 million doses of Covaxin in bulk form,” the company added.

According to the government of India, a staggering 220.66 crore doses, including second doses and booster doses, have been administered in the country as part of the national vaccination drive. The number of daily vaccinations has recently hovered around a few hundred.

Bharat Biotech to develop antigen bank of 10 Million iNCOVACC

Although Covishield and Covaxin were widely used earlier due to their early mover advantage against the pandemic, thereafter the first intranasal vaccine, iNCOVACC, developed by Bharat Biotech was also introduced. “There have been several requests for large-scale supplies of iNCOVACC. We will develop an antigen bank of 10 million doses as a stockpile. Capacity for iNCOVACC is very large and can be scaled up as required,” the company said.

COVAXIN

The spotlight has turned on vaccine availability in the country, with states urging the Centre to ramp up the supplies. At a recent meeting convened by Union Health Minister Mansukh Mandaviya to discuss COVID-19 cases and preparedness in the states, Telangana Health Minister T. Harish Rao appealed to the Centre to make adequate stocks of the vaccine available. Rao pointed out that the vaccination program had come to a standstill in the state after the Centre stopped supplies.

As the vaccination drive in India faces a lull, the country needs to ramp up its supplies and accelerate the vaccination program to ensure its citizens’ safety.

TAGGED: bharat biotech incovacc, Covaxin, COVAXIN Availability 2023, COVAXIN latest updates
Share This Article
Twitter Email Copy Link Print
Previous Article Ariana Grande's Powerful Message: Embrace Body Diversity, and Spread Kindness Ariana Grande’s Powerful Message: Embrace Body Diversity, and Spread Kindness
Next Article Europa League Drama: Sevilla and Man Utd Draw 2-2 with Own Goals Europa League Drama: Sevilla and Man Utd Draw 2-2 with Own Goals

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

Zemoso to create 2000 jobs; New Openings for Women Returnees

Nine-year-old Hyderabad headquartered product studio Zemoso, has announced today that is targeting to have an…

By TheNewsFacts

PM Modi Champions Media’s National Impact at New INS Towers, Mumbai

July 14, 2024: After inaugurating the Indian Newspaper Society (INS) Secretariat in Mumbai's Bandra Kurla…

By SK Panicker

Laughter Queen Bharti Singh, Haarsh Share a Great News

Bharti Singh and Haarsh Limbachiyaa made a joyous announcement. The couple shared to their fans,…

By TheNewsFacts

You Might Also Like

Dr. Krishna Ella Receives Johns Hopkins Highest Medal of Honor
Latest News

COVAXIN Creator Dr. Krishna Ella Wins Prestigious Johns Hopkins Award

By TheNewsFacts
COVAXIN
Trending News

Covaxin: Facts vs. Fiction – Separating Truth from Misinformation

By TheNewsFacts
Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau
COVAXIN safety First
Latest News

COVAXIN Safety Assured: Bharat Biotech Puts Safety First

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?